Doma Perpetual Capital Management LLC's Schedule 13D Filing for Pacira BioSciences, Inc.

Doma Perpetual Capital Management LLC, along with related entities and Pedro Escudero, filed a Schedule 13D with the SEC regarding their ownership of Common Shares in Pacira BioSciences, Inc. The filing indicates that Doma, on behalf of Doma Master Fund and The John Templeton Foundation, purchased a total of 2,699,618 Common Shares, representing 5.7% of the outstanding shares. Pedro Escudero also purchased 159,000 shares individually. The purchases were made with the intent to influence the Issuer but without the intention of taking full control. The Reporting Persons are not currently contemplating a merger, reorganization, or changes in management, but may consider such actions if the Common Shares underperform. The filing also details the sources of funds used for the purchases and the transactions' dates and prices.